Fatality rate, risk factors, and functional decline in peritoneal dialysis patients with coronavirus disease 2019: A

Piyatida Chuengsaman1, Sarinya Boongird2, Phongsak Dandecha3

  • 1Banphaeo-Charoenkrung Peritoneal Dialysis Center, Banphaeo Dialysis Group, Banphaeo Hospital, Bangkok, Thailand.

Frontiers in Medicine
|December 5, 2022
PubMed

Insights

Peritoneal dialysis patients face a high COVID-19 fatality rate, with functional impairment and the Delta variant increasing risks. Vaccination and corticosteroid therapy were associated with reduced mortality in these patients.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Epidemiology

Background:

  • Extensive research exists on coronavirus disease 2019 (COVID-19) mortality in hemodialysis patients.
  • Data regarding COVID-19 outcomes in peritoneal dialysis (PD) patients are limited.
  • Understanding COVID-19's impact on PD patients is crucial for targeted interventions.

Purpose of the Study:

  • To determine the 28-day COVID-19-related fatality rate in peritoneal dialysis patients.
  • To identify predictors associated with mortality in PD patients diagnosed with COVID-19.
  • To assess changes in functional status among PD patients during COVID-19 infection.

Main Methods:

  • Nationwide cohort study utilizing the InCov19-PD registry (August 2021 - July 2022).
  • Inclusion of 1,487 eligible peritoneal dialysis patients.
  • Multivariable Cox regression analysis to identify mortality predictors and assess functional status changes.

Main Results:

  • A 28-day COVID-19 case fatality rate of 13% (196 deaths) was observed among PD patients.
  • Independent predictors of increased mortality included functional impairment, SARS-CoV-2 Delta variant infection, and need for respiratory support.
  • COVID-19 vaccination and corticosteroid therapy were associated with a reduced risk of death; functional independence significantly declined during infection.

Conclusions:

  • Peritoneal dialysis patients exhibit a high 28-day COVID-19 fatality rate.
  • Key predictors of mortality in PD patients mirror those identified in hemodialysis populations.
  • Significant functional deterioration is a common outcome for PD patients during COVID-19.
Abstract

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
70
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
84
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
428
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
92
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
104
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
60